Arrow Generiques, 26 Pharmaceutical Import Profile — France (DGFT 2022–2026)

Name: Arrow Generiques, 26 Pharmaceutical Import Records from India — 2 Products, $157.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Arrow Generiques, 26 — Pharmaceutical Importer Profile (2026) | 2 Products, $157.6K Trade | TransData Nexus

Arrow Generiques, 26

Pharmaceutical Importer · France · Nutritional Supplements Focus · $157.6K Total Trade · DGFT Verified

Arrow Generiques, 26 is a pharmaceutical importer based in France with a total trade value of $157.6K across 2 products in 2 therapeutic categories. Based on 15 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Arrow Generiques, 26 sources from 1 verified Indian supplier, with Aurobindo Pharma Limited accounting for 100.0% of imports.

Arrow Generiques, 26 — Import Portfolio & Supplier Network

Arrow Generiques, 26 import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Arrow Generiques, 26?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Aurobindo Pharma Limited	$1.4M	155	100.0%

Arrow Generiques, 26 sources from 1 verified Indian supplier across 74 distinct formulations. The sourcing is highly concentrated — Aurobindo Pharma Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Arrow Generiques, 26 Import?

Formulation	Value	Ships
Cyamemazine tablets 25MG (cyamemazine arrow 25 MG, comprima pelliculasacable)	$72.7K	3
Pregabalin capsules 50MG(84's)(40782pak)(pregabaline arrow 50MG gelule)	$59.9K	3
Macrogol 4000 powder for oral solution insachet10g(macrogol4000 arrow10g,poudrepour solution buvable en sdachet	$50.1K	3
Amoxicillin tablets 1000MG(76160pak)(14's)(amoxicilline arrow lab 1 g, comprim dispersible)	$50.0K	1
Gabapentin capsules 300MG (90's)(26460pak)(gabapentine arrow generiques 300 MG,gelule)	$50.0K	1
Hydrochloro thiazide tablets 25MG (30's)(162419pak)(hydrochlorothiazide arrow 25 MG, comprim scable)	$50.0K	1
Propranolol tablets 40MG (propranolol arrow 40 MG, comprim pellicul scable) (50's) (77112 packs)	$50.0K	1
Lercanidipine tablets 10MG (lercanidipine arrow 10 MG, comprim pellicul scable) (90's) (19632 packs)	$48.9K	1
Eplerenone tablets 50MG (eplerenone arrow 50MG, comprim pellicul)	$47.7K	3
Mirtazapine tablets 15MG (3x10's)(67392pak)(mirtazapine arrow generiques 15 MG,comprime pellicule)	$45.6K	1
Atorvastatin 20 MG tablets(31744pak)(90's)(atorvastatine arrow generiques 20 MG, comprime pellicule)	$45.6K	1
Melatonin tablets 2 MG (30's)(66602pak)(melatonine arrow 2 MG, comprim libration prolong)	$43.1K	3
Gabapentin capsules 300MG(23640pak)(90's)(gabapentine arrow generiques 300 MG, gelule)	$41.3K	1
Atorvastatin 40 MG tablets (90's)(16320pak)(atorvastatine arrow generiques 40 MG,comprime pellicule)	$38.6K	3
Abacavir sulfate and lamivudine tablets600/300MG (3x10's)(1895pak)(abacavir/lamivudine arrow 600 MG/300 MG,comprim	$34.3K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Melatonin	Nutritional Supplements	$112.2K	12	1.2%	16
2	Acarbose	Advanced Diabetes Medications	$45.5K	3	0.7%	13

Arrow Generiques, 26 imports 2 pharmaceutical products across 2 categories into France totaling $157.6K.

Arrow Generiques, 26 — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Arrow Génériques, also known as Laboratoire Arrow, is a French pharmaceutical company specializing in the distribution of generic medicines and health products. Established in 2000, the company is headquartered at 26 Avenue Tony Garnier, 69007 Lyon, France. With a capital of €36,945,840, Arrow Génériques operates as a simplified joint-stock company (SAS) and employs approximately 238 people.

The company offers a diverse portfolio of over 800 references, including generic drugs, branded medicines, biosimilars, health products, and medical devices. These products are distributed across both the retail and hospital markets in France. Arrow Génériques plays a significant role in the French pharmaceutical distribution network, ensuring the availability of cost-effective and high-quality medications to meet the needs of healthcare providers and patients.

2Distribution Network

Arrow Génériques operates its distribution network from its headquarters in Lyon, France. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's extensive product portfolio and market presence suggest a well-established distribution infrastructure. This network is designed to efficiently supply both retail pharmacies and hospital facilities across France, ensuring timely delivery and availability of pharmaceutical products.

3Industry Role

In the French pharmaceutical supply chain, Arrow Génériques functions primarily as a wholesaler and distributor. The company imports and distributes a wide range of pharmaceutical products, including generic medicines, branded drugs, biosimilars, health products, and medical devices. By offering these products to both retail and hospital markets, Arrow Génériques plays a crucial role in enhancing the accessibility and affordability of medications within the French healthcare system.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Arrow Generiques, 26

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Arrow Génériques demonstrates a high level of sourcing concentration, importing finished pharmaceutical formulations exclusively from a single supplier, Aurobindo Pharma Limited. Between 2022 and 2026, the company imported products totaling $158,000 USD across 15 shipments, with Aurobindo Pharma Limited accounting for all these transactions. This indicates a strategic partnership or reliance on Aurobindo Pharma Limited for its product offerings.

The concentration on a single supplier can present both advantages and risks. On the positive side, it may lead to favorable terms, streamlined logistics, and a consistent product quality. However, dependency on one supplier also exposes Arrow Génériques to potential supply chain disruptions, price fluctuations, or changes in the supplier's business operations. The stability of this relationship is crucial for maintaining uninterrupted product availability and meeting market demand.

2Supply Chain Resilience

The resilience of Arrow Génériques' supply chain, particularly concerning its Indian supplier, Aurobindo Pharma Limited, is a critical factor in ensuring consistent product availability. While the company imports a diverse range of 74 unique formulations, the exclusive sourcing from a single supplier may limit its ability to mitigate potential disruptions. The absence of backup suppliers and the concentration of shipments through a single route could pose challenges in the event of logistical issues or regulatory changes affecting the primary supplier.

Importing Pharmaceuticals into France — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for France

1Regulatory Authority & Framework

In France, the primary regulatory authority overseeing pharmaceutical imports and distribution is the Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM). The ANSM is responsible for ensuring the safety, efficacy, and quality of health products available in the French market. Key legislation governing pharmaceutical imports includes the French Public Health Code, which outlines the requirements for marketing authorization, importation, and distribution of medicinal products.

For Indian generics to be marketed in France, they must undergo a marketing authorization process, which includes demonstrating bioequivalence to the reference product. This process ensures that the generic product performs in the same manner as the original branded product, providing the same therapeutic benefit to patients.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in France are stringent. Importers must obtain an authorization from the ANSM, which involves demonstrating compliance with Good Manufacturing Practice (GMP) standards. The ANSM recognizes GMP certifications from various international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications ensure that manufacturing processes meet the required quality standards.

Arrow Generiques, 26 — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Arrow Génériques' focus on importing finished pharmaceutical formulations from India, particularly in the categories of nutritional supplements and advanced diabetes medications, aligns with market demand in France. The prevalence of diabetes in France has led to a consistent need for effective management solutions, driving the demand for advanced diabetes medications. Nutritional supplements also cater to a health-conscious population seeking preventive healthcare options.

By sourcing these products from India, Arrow Génériques leverages the country's robust pharmaceutical manufacturing capabilities and cost advantages, enabling the company to offer competitive pricing and a diverse product range to the French market.

2Sourcing Profile

Arrow Génériques' sourcing strategy is characterized by importing generic drugs and formulations from India, focusing on finished pharmaceutical products rather than active pharmaceutical ingredients (APIs) or bulk drugs. This approach allows the company to provide ready-to-market products that meet the regulatory standards of the French market. The preference for sourcing from India is likely due to the country's established reputation for producing high-quality generics at competitive prices, making it an attractive option for pharmaceutical importers.

3Market Positioning

Seller's Guide — How to Become a Supplier to Arrow Generiques, 26

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For new Indian suppliers, there is a realistic opportunity to enter the French market by partnering with distributors like Arrow Génériques. While the existing exclusive relationship between Arrow Génériques and Aurobindo Pharma Limited may present challenges, other avenues exist. By identifying and engaging with other pharmaceutical distributors and importers in France, Indian exporters can diversify their market presence and reduce reliance on a single distribution channel. Additionally, exploring direct partnerships with healthcare providers or participating in public tenders can further enhance market penetration.

2Requirements & Qualifications

Indian exporters seeking to supply pharmaceutical products to Arrow Génériques and the French market must ensure compliance with several key requirements. Products must have marketing authorization from the ANSM, demonstrating bioequivalence to reference products. Manufacturers should hold GMP certifications recognized by the ANSM, such as EU GMP,

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Arrow Generiques, 26

What products does Arrow Generiques, 26 import from India?

Arrow Generiques, 26 imports 2 pharmaceutical products across 2 categories. Top imports: Melatonin ($112.2K), Acarbose ($45.5K).

Who supplies pharmaceuticals to Arrow Generiques, 26 from India?

Arrow Generiques, 26 sources from 1 verified Indian suppliers. The primary supplier is Aurobindo Pharma Limited (100.0% of imports, $1.4M).

What is Arrow Generiques, 26's total pharmaceutical import value?

Arrow Generiques, 26's total pharmaceutical import value from India is $157.6K, based on 15 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Arrow Generiques, 26 focus on?

Arrow Generiques, 26 imports across 2 categories. The largest: Nutritional Supplements (71.1%), Advanced Diabetes Medications (28.9%).

Get Full Arrow Generiques, 26 Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.